112.00

0.42% 0.47

After Hours: 112.00

Lemaitre Vascular Inc (LMAT)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Lemaitre Vascular Inc stock is traded at $112.00, with a volume of 225.46K. It is up +0.42% in the last 24 hours and up +3.24% over the past month. LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Previous Close:

$111.53

Open:

$111.68

24h Volume:

225.46K

Relative Volume:

1.02

Market Cap:

$2.56B

Revenue:

$249.60M

Net Income/Loss:

$57.73M

P/E Ratio:

44.55

EPS:

2.5139

Net Cash Flow:

$74.47M

1W Performance:

-0.36%

1M Performance:

+3.24%

6M Performance:

+29.82%

1Y Performance:

+39.23%

1-Day Range:

$109.94

$113.83

1-Week Range:

$106.38

$113.87

52-Week Range:

$78.35

$118.01

Lemaitre Vascular Inc Stock (LMAT) Company Profile

Name

Lemaitre Vascular Inc

Sector

Healthcare (1106)

Industry

Medical Instruments & Supplies (56)

Phone

781-221-2266

Address

63 SECOND AVENUE, BURLINGTON, MA

Employee

655

Twitter

@LMAT_Vascular

Next Earnings Date

2026-05-05

Latest SEC Filings

LMAT's Discussions on Twitter

Compare LMAT vs ISRG, BDX, MDLN, ALC, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LMAT Lemaitre Vascular Inc	112.00	2.55B	249.60M	57.73M	74.47M	2.5139
ISRG Intuitive Surgical Inc	451.38	160.21B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	144.17	41.62B	21.92B	1.76B	2.63B	6.1223
MDLN Medline Inc	45.32	37.37B	28.43B	1.16B	1.26B	1.4457
ALC Alcon Inc	74.45	35.82B	10.40B	980.00M	1.61B	1.9749
RMD Resmed Inc	207.88	30.38B	5.40B	1.49B	1.78B	10.12

Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-06-25	Upgrade	Barrington Research	Mkt Perform → Outperform
Feb-28-25	Downgrade	Barrington Research	Outperform → Mkt Perform
Feb-28-25	Downgrade	Oppenheimer	Outperform → Perform
Feb-13-25	Initiated	Wells Fargo	Equal Weight
Oct-15-24	Initiated	Cantor Fitzgerald	Neutral
Aug-02-24	Resumed	Lake Street	Buy
May-31-24	Resumed	ROTH MKM	Buy
Apr-26-24	Upgrade	Stifel	Hold → Buy
Feb-06-24	Resumed	KeyBanc Capital Markets	Sector Weight
Oct-23-23	Initiated	JMP Securities	Mkt Outperform
Sep-06-23	Initiated	Oppenheimer	Outperform
Aug-03-23	Downgrade	Jefferies	Buy → Hold
May-03-23	Upgrade	Barrington Research	Mkt Perform → Outperform
Oct-28-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Sep-16-21	Initiated	Jefferies	Buy
Feb-12-21	Initiated	KeyBanc Capital Markets	Sector Weight
Mar-16-20	Upgrade	Sidoti	Neutral → Buy
Oct-24-19	Downgrade	First Analysis Sec	Strong Buy → Outperform
Oct-24-19	Upgrade	Lake Street	Hold → Buy
Oct-14-19	Upgrade	First Analysis Sec	Outperform → Strong Buy
Jul-25-19	Reiterated	Barrington Research	Outperform
Jul-25-19	Upgrade	First Analysis Sec	Neutral → Outperform
Oct-08-18	Upgrade	Barrington Research	Mkt Perform → Outperform
Oct-08-18	Upgrade	ROTH Capital	Neutral → Buy
Jun-08-18	Resumed	ROTH Capital	Buy
Apr-26-18	Downgrade	Stifel	Buy → Hold
Apr-26-18	Upgrade	The Benchmark Company	Hold → Buy
Oct-27-17	Downgrade	First Analysis Sec	Overweight → Equal-Weight
Oct-27-17	Downgrade	The Benchmark Company	Buy → Hold
Jul-10-17	Downgrade	Canaccord Genuity	Buy → Hold
Jul-10-17	Downgrade	The Benchmark Company	Buy → Hold
Mar-21-17	Initiated	First Analysis Sec	Overweight
Feb-22-17	Downgrade	Barrington Research	Outperform → Mkt Perform
Sep-22-16	Downgrade	Sidoti	Buy → Neutral
Jul-28-16	Reiterated	Barrington Research	Outperform
Feb-25-16	Reiterated	Barrington Research	Outperform

View All

Lemaitre Vascular Inc Stock (LMAT) Latest News

07:20 AM

Why LeMaitre Vascular Stock Is Sinking Today - TipRanks

07:20 AM

06:10 AM

LeMaitre Vascular Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga

06:10 AM

06:05 AM

LeMaitre (NASDAQ:LMAT) Posts Q1 CY2026 Sales In Line With Estimates - Yahoo Finance

04:42 AM

04:34 AM

LeMaitre Vascular (NASDAQ: LMAT) posts strong Q1 2026 results and raises 2026 growth outlook - Stock Titan

04:34 AM

04:18 AM

(LMAT) LeMaitre Vascular, Inc. Expects Q2 Revenue Range $70.5M$72.5M - marketscreener.com

04:18 AM

04:17 AM

Earnings Flash (LMAT) LeMaitre Vascular, Inc. Reports Q1 Revenue $66.6M, vs. FactSet Est of $66.7M - marketscreener.com

04:17 AM

04:05 AM

BRIEF-LeMaitre Vascular Q1 Sales USD 66.551 Million Vs. IBES Estimate USD 66.5 Million - TradingView

04:05 AM

LeMaitre lifts 2026 outlook after 11% sales growth, sets dividend - Stock Titan

04:05 AM

10:45 AM

LeMaitre Vascular earnings in focus: Can margin gains continue? By Investing.com - Investing.com Nigeria

10:45 AM

10:42 AM

LeMaitre Vascular earnings in focus: Can margin gains continue? - Investing.com

10:42 AM

02:40 AM

MSN Money - MSN

02:40 AM

May 04, 2026

LeMaitre (LMAT) Q1 Earnings Report Preview: What To Look For - Yahoo Finance

May 04, 2026

May 03, 2026

(LMAT) Risk Channels and Responsive Allocation - Stock Traders Daily

May 03, 2026

May 01, 2026

How Investors May Respond To LeMaitre Vascular (LMAT) Profit Boost From Strong Operating Leverage - Yahoo Finance

May 01, 2026

Conestoga Capital Advisors LLC Trims Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat

May 01, 2026

Apr 29, 2026